• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Was the US DHS Release of 12 Million Treatment Doses from the National Strategic Stockpile Appropriate?

the doctor

Retired 2010
No. It was not a strategic deployment. It was a politically motivated tactical deployment and an entirely inappropriate use of a strategic resource in my view.

The National Strategic Stockpile of materials is just that; strategic. What Sec. Napolitano did was deploy a strategic resource for a politically tactical reason. This is very worrisome because it shows that she does not have a grasp of just how severe the current situation is.

Why? Simply put strategic resources must be maintained in reserve for use in as a last resort. They are resources that a country reserves for use when its very existence is threatened. The anti-viral drugs maintained in the National Strategic Stockpile have already been designated for use by the CDC?s updated rationing plan, one I support. The diversion of a quarter of this precious resource for non-targeted civilian use for treatment of those with influenza within the states most affected by the virus is a violation of the policy adopted by the CDC .

This is an important issue because the doses released by DHS from the strategic stockpile have been earmarked for use by fireman, policeman, EMS, the political leadership, nurses, doctors, pharmacists and many others responsible for maintaining our critical infrastructure including electric power, clean water and food on the table. While the drugs diverted by the Secretary for general use will save lives and all lives have great value, her choice to do so was not a humane one in the long run.

Why? The very lives that might be saved by this premature release of these strategic drugs may well be lost along with countless others as a result of the deaths of a similar number of the critical workers listed above if the pandemic becomes severe. What?s more, the recovery of our or any nation post pandemic will require the combined efforts of the very same critical workers. The fewer who survive the pandemic, the longer it will take for us to recover.

Secretary Napalitono?s misguided actions yesterday serve her and the administration by making the appearance that they are doing something. To the administration this move may appear as politically astute in the short-term since in the minds of the masses it suggests that the government it ?taking action? against the Swine Flu. What has not been clearly acknowledged however is that this action, for the reasons mentioned above is one that has potentially significant long-term sacrifices for both our citizens and national recovery post-pandemic.

Grattan Woodson, MD
 
Re: Was the US DHS Release of 12 Million Treatment Doses from the National Strategic Stockpile Appropriate?

My understanding is that each state's stockpiles are to be used first. Then request for and deployment of national stockpiles. Anyone with additional info.
 
Re: Was the US DHS Release of 12 Million Treatment Doses from the National Strategic Stockpile Appropriate?

the way i understand it "iam a professional firefighter.IAFF 1526"

we get our stock from the state they ran a few training drills on this about a year or so ago.

then it goes to the county the the county gives them out to each division.
 
Re: Was the US DHS Release of 12 Million Treatment Doses from the National Strategic Stockpile Appropriate?

Based on the statistical data we have, I personally believe the CDC/FDA should recommend treating only people who are in the age range of the pandemic fatalities (20-50) with any antivirals. Doing so would slow the rate of the resistance to the antivirals in the case of pandemic and allow us to treat those who it is most likely to be fatal too.
 
Re: Was the US DHS Release of 12 Million Treatment Doses from the National Strategic Stockpile Appropriate?

It appears that the DHS is in fact simply pre-positioning Tamiflu for future use not current use. In fact, Georgia is receiving an allocation and when the decision was made we had no cases although today we have a couple of suspects in Augusta.

So, while Sec Napolitano's statement suggested that the strategic stockpile was being released for current use, this is apparently not the case. What they seem to be doing in fact is putting out a portion of the stockpile now for use in the future, an entirely appropriate move given the facts.

GW
 
Re: Was the US DHS Release of 12 Million Treatment Doses from the National Strategic Stockpile Appropriate?

I hope that they rotate their stocks based on expiration, because it seems that at least 5 million doses (the initial US stockpile prior to the 20 million in 2006 and 24 million in 2008) are due to expire in April 2010. Even though in November 2008, the shelf life was increased to seven years from five years, these boxes will be stamped and may not have been stored in a manner that is conducive to the new shelf life extension that is only applicable in some countries.
 
Back
Top Bottom